MANNELLA, IOLE
 Distribuzione geografica
Continente #
NA - Nord America 323
AS - Asia 191
EU - Europa 186
SA - Sud America 28
AF - Africa 2
Totale 730
Nazione #
US - Stati Uniti d'America 313
SG - Singapore 142
IT - Italia 110
BR - Brasile 26
CN - Cina 23
IE - Irlanda 15
IN - India 11
DE - Germania 9
FI - Finlandia 9
CA - Canada 8
GB - Regno Unito 8
PL - Polonia 7
ES - Italia 6
FR - Francia 6
HK - Hong Kong 4
SE - Svezia 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
NL - Olanda 3
TW - Taiwan 3
DK - Danimarca 2
JP - Giappone 2
MX - Messico 2
NG - Nigeria 2
PT - Portogallo 2
UA - Ucraina 2
BO - Bolivia 1
KR - Corea 1
PH - Filippine 1
TH - Thailandia 1
VE - Venezuela 1
Totale 730
Città #
Los Angeles 103
Singapore 69
Santa Clara 66
Turin 40
Columbus 15
Dublin 15
Ashburn 12
Milan 11
Hefei 10
Rome 10
Chandler 9
Lappeenranta 7
Bradford 6
Chicago 6
Araraquara 4
Düsseldorf 4
Krakow 4
Québec 4
West Jordan 4
Barcelona 3
Beijing 3
Brooklyn 3
Jakarta 3
Nuremberg 3
Nyköping 3
Palermo 3
Toronto 3
Washington 3
Abuja 2
Alessandria 2
Belo Horizonte 2
Birmingham 2
Gainesville 2
Garbagnate Milanese 2
Hradec Králové 2
Jacksonville 2
Lisbon 2
Luni 2
Medford 2
Naples 2
New Hope 2
New York 2
Nice 2
Norfolk 2
Parma 2
Princeton 2
Pune 2
Taichung 2
Vercelli 2
Warsaw 2
Almirante Tamandaré 1
Amsterdam 1
Arraial do Cabo 1
Bangalore 1
Bangkok 1
Bari 1
Berlin 1
Birkerød 1
Boston 1
Caiabu 1
Campinas 1
Caraguatatuba 1
Central 1
Cheonan 1
Coacalco 1
College Station 1
Copenhagen 1
Curitiba 1
Divinópolis 1
Florence 1
Franca 1
Goiânia 1
Helsinki 1
Itaberaí 1
Itapecerica da Serra 1
Jacareí 1
Kanazawa 1
Kannur 1
Keystone Heights 1
Lauterbourg 1
Madrid 1
Manila 1
Marília 1
Montes Claros 1
Mount Pleasant 1
Munich 1
Newton 1
Noicattaro 1
Olinda 1
Olomouc 1
Puerto Cruz 1
Rio Paranaíba 1
Rivoli 1
San Luis Potosí City 1
Sant'Agapito 1
Santa Cruz 1
Santo Antônio do Descoberto 1
Sertãozinho 1
Stockholm 1
Taipei 1
Totale 520
Nome #
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 133
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer 108
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer 88
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 51
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer 49
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 46
Exploring Novel Compounds Targeting Mycobacterium tuberculosis Dihydroorotate Dehydrogenase: SAR Analysis and Biological Activity 41
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role. 40
OPTIMIZING SYNTHESIS AND IN VIVO EVALUATION OF MEDS433: ADVANCING TO PRECLINICAL DEVELOPMENT IN ACUTE MYELOID LEUKEMIA 34
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis 33
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 31
Scaling up synthesis and in vivo evaluation of MEDS433: a promising preclinical candidate targeting AML 28
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS 25
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 24
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS 23
Totale 754
Categoria #
all - tutte 3.549
article - articoli 0
book - libri 0
conference - conferenze 3.033
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 0 0 8 11 10
2022/202369 7 5 6 3 6 22 5 3 3 2 2 5
2023/2024228 15 6 3 5 10 13 125 10 1 11 12 17
2024/2025428 2 33 42 56 76 36 8 9 67 19 40 40
Totale 754